#United States #New York #Aidoc #Medicare #CARE Multi-Triage

Aidoc's CARE Body CT Multi-Triage Gains Medicare Support

In a significant breakthrough for healthcare technology, Aidoc has announced that its CARE™ Multi-Triage CT device has been approved for the New Technology Add-on Payment (NTAP) by the Centers for Medicare & Medicaid Services (CMS). This crucial decision will enable eligible hospitals to receive add-on payments when using Aidoc's AI technology, which enhances the triage process for patients presenting a variety of acute conditions.

This approval marks a vital milestone in expanding access to innovative medical technologies, allowing healthcare providers to adopt advanced solutions while mitigating financial risks. Starting October 1, 2026, hospitals implementing the CARE Body CT Multi-Triage will follow a standardized billing process for eligible Medicare Fee For Service inpatient cases using this FDA-cleared technology.

The NTAP program is designed to facilitate Medicare patients' access to cutting-edge medical devices, fostering faster market adoption of new technologies. According to studies, over 40% of CT imaging in the U.S. is dedicated to abdominal imaging, with more than half of acute scans occurring in inpatient and emergency departments. The introduction of the NTAP program will further streamline procedures as it provides health systems with the framework for implementation and utilization tracking.

Aidoc’s CARE Body CT Multi-Triage uses artificial intelligence to assist healthcare professionals by flagging urgent findings across a wide spectrum of conditions in CT scans of the abdomen, chest, and pelvis. By prioritizing cases that need immediate attention, the technology aims to enhance patient treatment timelines, ensuring that those with critical conditions receive timely interventions.

Elad Walach, CEO and co-founder of Aidoc, emphasized the pressing need for such innovations, stating, "Health systems are under increasing pressure to help patients receive accurate diagnoses sooner while managing growing imaging demand and persistent workforce shortages. By creating a reimbursement pathway for eligible use of diagnostic AI, the NTAP program is helping patients get earlier access to this transformative new technology."

The decision to approve the NTAP represents not only a victory for Aidoc but also a step toward alleviating financial burdens on health systems that seek to integrate validated AI solutions into their operations. In essence, this mechanism can significantly reduce barriers to entry for healthcare providers, equipping them to invest in impactful clinical technologies that could ultimately lead to better patient outcomes.

For hospitals, assessing individual cases against CMS requirements is essential for determining eligibility for reimbursement under the Medicare Fee for Service program. The path cleared by the NTAP highlights the commitment to expanding access to powerful AI tools in healthcare, ultimately aiming to transform patient diagnostics and clinical workflows positively.

About Aidoc

Aidoc stands out as a global leader in diagnostic AI, focusing on enhancing physician efficiency and improving patient safety. Leveraging its clinical-grade CARE™ foundation model and aiOS™ operating system, Aidoc seamlessly integrates AI within clinical workflows, enabling healthcare facilities to manage, deploy, and scale multiple FDA-cleared solutions. The data provided by Aidoc shows that it has reviewed over 150 million patient cases and is operational in nearly 2,000 hospitals worldwide, assisting in clinical decisions for approximately 60 million patients each year. This momentum continues to influence the medical field profoundly as innovations such as the CARE Body CT Multi-Triage redefine how healthcare professionals approach diagnostics and patient care.